Can pay-for-performance to primary care providers stimulate appropriate use of antibiotics?
(2015) In Working Paper / Department of Economics, School of Economics and Management, Lund University- Abstract
- Resistance to antibiotics is a major threat to the effectiveness of modern health care. This study examines if pay-for-performance (P4P) to care providers stimulates the appropriate use of antibiotics; in particular, if P4P can induce a substitution away from broad-spectrum antibiotics, which contribute more to the development of resistance, to less resistance-driving types. In the context of Swedish primary care, we study the introduction of P4P indicators encouraging substitution of narrow-spectrum antibiotics for broad-spectrum antibiotics in the treatment of children with respiratory tract infections (RTI). During 2006-2013, 8 out of 21 county councils introduced such P4P indicators in their reimbursement schemes for primary care... (More)
- Resistance to antibiotics is a major threat to the effectiveness of modern health care. This study examines if pay-for-performance (P4P) to care providers stimulates the appropriate use of antibiotics; in particular, if P4P can induce a substitution away from broad-spectrum antibiotics, which contribute more to the development of resistance, to less resistance-driving types. In the context of Swedish primary care, we study the introduction of P4P indicators encouraging substitution of narrow-spectrum antibiotics for broad-spectrum antibiotics in the treatment of children with respiratory tract infections (RTI). During 2006-2013, 8 out of 21 county councils introduced such P4P indicators in their reimbursement schemes for primary care providers. We employ municipality-level register data covering all purchases of RTI related antibiotics and exploit the staggered introduction of pay-for-performance in a difference-in-differences analysis. Despite that the monetary incentives were small, we find that P4P significantly increased narrow-spectrum antibiotics' share of RTI antibiotics consumption. We further find larger effects in areas where there were many private providers, where the incentive was formulated as a penalty rather than a reward, and where all providers were close to a P4P target. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/8499755
- author
- Anell, Anders LU ; Ellegård, Lina Maria LU and Dietrichson, Jens LU
- organization
- publishing date
- 2015
- type
- Working paper/Preprint
- publication status
- published
- subject
- keywords
- pay-for-performance, antibiotics resistance, primary care
- in
- Working Paper / Department of Economics, School of Economics and Management, Lund University
- issue
- 36
- pages
- 34 pages
- publisher
- Department of Economics, Lund University
- language
- English
- LU publication?
- yes
- id
- 34847430-aeb0-4a68-8801-5cef94b3fa85 (old id 8499755)
- alternative location
- http://project.nek.lu.se/publications/workpap/papers/wp15_36.pdf
- date added to LUP
- 2016-04-04 11:19:41
- date last changed
- 2018-11-21 21:04:07
@misc{34847430-aeb0-4a68-8801-5cef94b3fa85, abstract = {{Resistance to antibiotics is a major threat to the effectiveness of modern health care. This study examines if pay-for-performance (P4P) to care providers stimulates the appropriate use of antibiotics; in particular, if P4P can induce a substitution away from broad-spectrum antibiotics, which contribute more to the development of resistance, to less resistance-driving types. In the context of Swedish primary care, we study the introduction of P4P indicators encouraging substitution of narrow-spectrum antibiotics for broad-spectrum antibiotics in the treatment of children with respiratory tract infections (RTI). During 2006-2013, 8 out of 21 county councils introduced such P4P indicators in their reimbursement schemes for primary care providers. We employ municipality-level register data covering all purchases of RTI related antibiotics and exploit the staggered introduction of pay-for-performance in a difference-in-differences analysis. Despite that the monetary incentives were small, we find that P4P significantly increased narrow-spectrum antibiotics' share of RTI antibiotics consumption. We further find larger effects in areas where there were many private providers, where the incentive was formulated as a penalty rather than a reward, and where all providers were close to a P4P target.}}, author = {{Anell, Anders and Ellegård, Lina Maria and Dietrichson, Jens}}, keywords = {{pay-for-performance; antibiotics resistance; primary care}}, language = {{eng}}, note = {{Working Paper}}, number = {{36}}, publisher = {{Department of Economics, Lund University}}, series = {{Working Paper / Department of Economics, School of Economics and Management, Lund University}}, title = {{Can pay-for-performance to primary care providers stimulate appropriate use of antibiotics?}}, url = {{http://project.nek.lu.se/publications/workpap/papers/wp15_36.pdf}}, year = {{2015}}, }